Ibali lesigulana | I-Acute Myeloid Leukemia (AML-M2) Survivor: Iminyaka eli-9 emva kokufakelwa, ukwamkela amandla ethemba kunye nokuzalwa ngokutsha
Ngowama-2014, kwiinyanga ezintlanu nje emva kokuba ngutata, uMnu. Liang (igama elingelolakhe) wafumana uxilongo olubi kakhulu: i-Acute Myeloid Leukemia (AML-M2). Ihlabathi lakhe laguquka njengoko wayebona iinyani ezinzima zobuthathaka bobomi. Nangona wayefumana unyango lwe-chemotherapy kabini apha ekhaya, imeko yakhe ayizange ilungiswe, nto leyo eyabangela ukuba yena nosapho lwakhe bafune unyango olukhethekileyo ngakumbi. Bafika kwiSibhedlele saseLu Daopei, apho isicwangciso sonyango esipheleleyo senziwa nguGqr. Zhang Xian kunye neqela kwiSebe leHematology, nto leyo eyazisa ithemba kusapho njengoko uLiang wayengena ekuphumleni ngokupheleleyo.
Nangona kunjalo, idabi lalingekapheli. Enenjongo yokufumana unyango oluhlala luhleli, uLiang wathunyelwa kwiqela likaGqr. Zhou Jirui ukuze alungiselele ukufakelwa i-haploidentical stem cell esindisa ubomi. Inkqubo yokufakelwa yayinzima, iphawulwa ziintlungu ezinkulu zomzimba, ubunzima bengqondo bemijikelo emininzi ye-chemotherapy, kunye noxinzelelo lwezemali. Sekunjalo, kulo lonke eli thuba, uLiang wabambelela kwinkolelo engagungqiyo kumandla obomi nothando.
Ngomhla we-15 kweyoMdumba ngo-2015—kwiintsuku ezimbalwa ngaphambi koNyaka oMtsha waseTshayina—wafumana utyando olutshintsha ubomi bakhe kwiiseli ze-stem zikayise, nto leyo eyaphawula ukuqala kokuzalwa kwakhe ngokutsha. Ukuchacha okwalandelayo kwakunzima, kunye neengxaki ezifana ne-hemorrhagic cystitis, i-cytomegalovirus (CMV) viremia, kunye nesifo se-graft-versus-host (GVHD), kodwa ngononophelo olukhethekileyo lukaGqr. Zhou kunye neqela lakhe lezonyango elizinikeleyo, uLiang waphucuka kancinci kancinci.
Emva kweminyaka elithoba emva kokufakelwa isibeleko, uLiang uphilile ngokupheleleyo kwaye uphila ubomi obuqhelekileyo, kokubini kwicandelo lakhe lomntu kunye nelomsebenzi. Uvavanyo lwakhe lwezonyango lubonisa ukuphumla okuzinzileyo, kunye namanqanaba e-AML1-ETO fusion gene ehla kancinci, kwaye imeko yakhe iyaqhubeka izinzile ngaphandle kwempawu zokubuyela umva.
Ecinga ngohambo lwakhe, uLiang wathi, “Phakathi kwentlungu nokubandezeleka, ndabambelela kwithemba, elaba kukukhanya okundikhokela ebumnyameni. Ubomi bufana nembewu; ngothando nenkathalo, buya kukhula buchume. Ndikholelwa ukuba nokuba siphi na, ukuba sibambelela kukholo lwethu, sinokuma siphakame njengomthi, sinyamezele nasiphi na isaqhwithi.”
Uvakalise umbulelo wakhe omkhulu kuGqr. Zhou, uGqr. Wang Jingyu, kunye nabasebenzi abangongikazi kwiSibhedlele iLu Daopei, abanobuchule obungagungqiyo kunye novelwano lwabo olumnike ithuba lesibini ebomini. Ukwambulele ngokusuka entliziyweni umfazi wakhe, owamnike uthando olungapheliyo kunye nenkxaso ngelixa enyamekela umntwana wabo ngamaxesha anzima kakhulu.
Ibali likaLiang alilo nje kuphela loloyiso lwezonyango kodwa likwangqina uthando, inkalipho, namandla okukholelwa. Lisebenza njengenkuthazo kubo bonke abaguli abalwa iimfazwe zabo. Umyalezo wakhe kwabanye abaguli: "Kholelwa emandleni ethemba, kholwa koogqirha bakho, kholwa kusapho lwakho, kwaye okona kubaluleke kakhulu, kholwa kuwe. Nokuba indlela engaphambili ibonakala inzima kangakanani na, xa unokholo entliziyweni yakho, uya kukhanya kakhulu, ukhanyise indlela eya phambili."
Imvelaphi yesigulane:
- Ubudala besigulana: 32
- Uxilongo: I-AML-M2 (ene-AML1-ETO fusion gene positive kunye ne-chromosome-Y engaqhelekanga)
- UnyangoEmva kokungaphumeleli kwe-chemotherapy, wenziwa utyando lwe-haploidentical stem cell esebenzisa iiseli zikayise ngoFebruwari 2015 kwiSibhedlele iLu Daopei.
- Iingxaki emva kokufakelwa: I-hemorrhagic cystitis, i-CMV viremia, kunye ne-acute GVHD (uhlobo lolusu).
- Ubume bangoku: Ukuphumla okuzinzileyo, iminyaka eli-9 emva kokufakelwa, ukuphila ubomi obusempilweni nobuqhelekileyo.
Ibali likaLiang lingqina impembelelo yonyango lwe-hematology lwanamhlanje olutshintsha ubomi, kunye nethemba lokuba isigulana ngasinye sinokulifumana ngonyango olunezakhono olunikezelwa kwiSibhedlele iLu Daopei.